I'm a little confused about what you are accusing him of here. Getting his daughter a data entry job?
Are you being deliberately obtuse?
Are you being deliberately obscure?
What is hard to understand about a pharmaceutical company - headed by an ex-lobbyist and the daughter of a US Senator whose actual management and leadership credentials appear to be not just lacking, but laughable - pursuing a business model that depends on an FDA-enforced monopoly that is, at least arguably, poorly justified by the best available medical evidence on generic alternatives?
Now it seems to be my turn to be deliberately obtuse, because I have no idea what you meant to imply by this.
Up until this point she was generally considered a respected leader within the industry, whose tenure saw the stock price rise by a proportion even more than the rise in price of Epipen. This is not a unique case, it is an industry trend. Do you think those industries that provide hyper-inflationary products - such as drug manufacturers, universities - are inherently more greedy than those making slightly deflationary products like TVs and personal computers? Even if they are for some reason, prices are supposed to supposed to communicate something about supply and demand. If there has been no significant change in supply or demand, and yet prices have gone up 600%, something has gone wrong to allow this to happen. It isn't a healthy, functioning market.